Home Accium BioSciences

Accium BioSciences

In operation
-
Ultra-sensitive Detection Platform Developer
Basic
Enterprise Profile

Basic Information

Accium BioSciences is the developer of an ultra-sensitive detection platform. Accium BioSciences is committed to providing high-quality micro-tracing data for your clinical or preclinical drug research. Accium offers reliable 14C/12C ratio measurements in clinical samples, supporting research in drug development and the medical research community.
Accium BioSciences, Inc.
Seattle,Washington,United States of America
15~50 people
May 01, 2004
info@acciumbio.com

Enterprise Profile

Industrial Sector
New Drug Development Clinical Trial Institution Information Technology Vendors Big Data and Cloud Computing Services CXO (Pharmaceutical Outsourcing Organization)
Technology
Biotechnology
Application Scenarios
Innovative Drugs Big Data